Dashboard
Manage Tickers

PTCTPTC THERAPEUTICS, INC.

Nasdaq ptcbio.com


$ 36.49 $ 3.23 (9.7 %)    

Friday, 21-Jun-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 480.84 $ -1.29 (-0.27 %)
DIA $ 391.56 $ -0.73 (-0.19 %)
SPY $ 544.47 $ -0.73 (-0.13 %)
TLT $ 93.96 $ 0.00 (0 %)
GLD $ 214.79 $ -3.38 (-1.55 %)
$ 36.52
$ 33.66
$ 0.00 x 0
$ 0.00 x 0
$ 33.66 - $ 36.54
$ 17.53 - $ 43.31
3,750,598
na
2.79B
$ 0.91
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-25-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 10-26-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 04-27-2023 03-31-2023 10-Q
6 02-21-2023 12-31-2022 10-K
7 10-27-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-03-2022 03-31-2022 10-Q
10 02-22-2022 12-31-2021 10-K
11 10-28-2021 09-30-2021 10-Q
12 07-29-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 10-29-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 04-30-2020 03-31-2020 10-Q
18 03-02-2020 12-31-2019 10-K
19 10-30-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 03-01-2019 12-31-2018 10-K
23 11-05-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-09-2018 03-31-2018 10-Q
26 03-06-2018 12-31-2017 10-K
27 11-02-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-08-2017 03-31-2017 10-Q
30 03-16-2017 12-31-2016 10-K
31 11-03-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-Q
34 02-29-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 07-31-2015 06-30-2015 10-Q
37 05-05-2015 03-31-2015 10-Q
38 03-02-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

asana-clover-health-investments-hertz-global-and-other-big-stocks-moving-higher-on-friday
Asana, Clover Health Investments, Hertz Gl...
06/21/2024 14:45:13

b-of-a-securities-maintains-underperform-on-ptc-therapeutics-raises-price-target-to-32
B of A Securities Maintains Underperform o...
06/21/2024 10:40:37

B of A Securities analyst Tazeen Ahmad maintains PTC Therapeutics (NASDAQ:PTCT) with a Underperform and raises the price tar...

jp-morgan-maintains-overweight-on-ptc-therapeutics-maintains-53-price-target
JP Morgan Maintains Overweight on PTC Ther...
06/20/2024 17:39:59

JP Morgan analyst Eric Joseph maintains PTC Therapeutics (NASDAQ:PTCT) with a Overweight and maintains $53 price target.

ptc-therapeutics-says-fda-lifts-clinical-hold-on-investigational-study-in-patients-with-rare-weak-nerve-cell-disorder
PTC Therapeutics Says FDA Lifts Clinical H...
06/20/2024 14:09:00

PTC Therapeutics released interim results from its Phase 2 PIVOT-HD study on PTC518 for Huntington's disease. The FDA has l...

ptc-therapeutics-shared-interim-results-from-phase-2-pivot-hd-study-of-ptc518-in-huntingtons-disease-showing-dose-dependent-lowering-of-mutant-huntingtin-protein-in-bloodcerebrospinal-fluid-and-favorable-trends-on-several-relevant-clinical-assessments
PTC Therapeutics Shared Interim Results Fr...
06/20/2024 10:34:04

- FDA lifts PTC518 partial clinical hold based on PIVOT-HD data

goldman-sachs-maintains-sell-on-ptc-therapeutics-raises-price-target-to-32
Goldman Sachs Maintains Sell on PTC Therap...
05/28/2024 15:46:41

Goldman Sachs analyst Paul Choi maintains PTC Therapeutics (NASDAQ:PTCT) with a Sell and raises the price target from $18 to...

ptc-therapeutics-announces-the-sepiapterin-maa-for-pku-has-been-validated-and-accepted-for-review-by-the-ema
PTC Therapeutics Announces The Sepiapterin...
05/28/2024 12:45:46

- Review of European marketing application for PKU now initiated -WARREN, N.J., May 28, 2024 /PRNewswire/ -- PTC Therapeutics, ...

citigroup-maintains-sell-on-ptc-therapeutics-raises-price-target-to-26
Citigroup Maintains Sell on PTC Therapeuti...
05/21/2024 18:01:17

Citigroup analyst David Lebowitz maintains PTC Therapeutics (NASDAQ:PTCT) with a Sell and raises the price target from $18 t...

jp-morgan-maintains-overweight-on-ptc-therapeutics-raises-price-target-to-53
JP Morgan Maintains Overweight on PTC Ther...
05/21/2024 16:07:17

JP Morgan analyst Eric Joseph maintains PTC Therapeutics (NASDAQ:PTCT) with a Overweight and raises the price target from $4...

goldman-sachs-maintains-sell-on-ptc-therapeutics-raises-price-target-to-32
Goldman Sachs Maintains Sell on PTC Therap...
05/21/2024 14:15:45

Goldman Sachs analyst Paul Choi maintains PTC Therapeutics (NASDAQ:PTCT) with a Sell and raises the price target from $18 to...

ptc-therapeutics-reports-the-european-commission-asked-chmp-to-review-its-january-opinion-on-renewal-of-marketing-authorization-for-translarna
PTC Therapeutics Reports The European Comm...
05/21/2024 12:46:47

-Reuters

jefferies-maintains-buy-on-ptc-therapeutics-raises-price-target-to-46
Jefferies Maintains Buy on PTC Therapeutic...
05/20/2024 17:35:16

Jefferies analyst Kelly Shi maintains PTC Therapeutics (NASDAQ:PTCT) with a Buy and raises the price target from $35 to $46.

why-virios-therapeutics-shares-are-trading-lower-by-around-48-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Virios Therapeutics Shares Are Trading...
05/20/2024 17:28:52

european-commission-requests-reevaluation-of-opinion-on-ptc-therapeutics-duchenne-dystrophy-drug-pauses-annual-guidance
European Commission Requests Reevaluation ...
05/20/2024 16:03:50

PTC Therapeutics announced that the European Commission has asked the CHMP to re-evaluate its negative opinion on the renewal o...

overseas-shipholding-micron-squarespace-incyte-and-other-big-stocks-moving-higher-on-monday
Overseas Shipholding, Micron, Squarespace,...
05/20/2024 15:37:53

Core News & Articles
Market-Moving News for May 20th
05/20/2024 12:37:59

PTCT: 27% | PTC Therapeutics Announces European Commission Returns Translarna Opinion to CHMP For Re-evaluation NKGN: 81% | NK...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
05/20/2024 12:06:50

ptc-therapeutics-paused-2024-revenue-guidance-as-it-struggles-to-weigh-the-impact-of-continued-authorization-of-translarna-in-europe
PTC Therapeutics Paused 2024 Revenue Guida...
05/20/2024 11:07:09

Given the inability to accurately forecast the upside impact of the continued authorization of Translarna in Europe on 2024 rev...

ptc-therapeutics-announces-european-commission-returns-translarna-opinion-to-chmp-for-re-evaluation
PTC Therapeutics Announces European Commis...
05/20/2024 11:04:26

PTC Therapeutics, Inc. (NASDAQ:PTCT) announced today that the European Commission (EC) has decided not to adopt the CHMP's ...

ptc-therapeutics-shares-are-trading-higher-after-the-fda-accepted-and-granted-priority-review-to-the-companys-bla-for-upstaza
PTC Therapeutics shares are trading higher...
05/14/2024 15:11:39

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)